Objective: To evaluate the clinical performance of a plasma arc light (Ortho LITE, 3M Unitek, Monrovia, CA, USA) against a conventional tungsten�quartz halogen curing light (Visilux 2, 3M Unitek, Monrovia, CA, USA) for direct orthodontic bonding.
Design: A single centre prospective randomized controlled clinical trial.
Setting: The Orthodontic Department at St Luke�s Hospital, Bradford, UK.
Subjects and methods: Forty-three consecutive patients requiring fixed appliances from the orthodontic waiting list. A split mouth technique was adopted; with quadrants randomly assigned to either the plasma arc light or the conventional halogen curing light and bonded directly with APC pre-adjusted edgewise brackets (3M Unitek, Monrovia, CA, USA).
Main outcome measure: Bracket failures.
Secondary outcome measures: Time taken to bond-up the appliances, patient sensitivity or discomfort during curing and time to replace failed brackets were investigated.
Results: No statistically significant difference in bracket failure rates over the full course of treatment was found between the plasma arc light (6.7%; 95% CI 4.5�10.0) and the halogen curing light (9.5%; 95% CI 6.8�13.1). There was no statistically significant difference in bracket survival times. The bond-up times were typically reduced by 204 seconds per patient with the plasma arc light. There were no differences in patient reported sensitivity or discomfort or rebond times.
Conclusion: The plasma arc light is a viable clinical alternative to the conventional halogen curing light with benefits for both the clinician and patient due to reduced bonding times.
© 2001-2024 Fundación Dialnet · Todos los derechos reservados